Analysis of patient samples revealed a positive correlation between SIRT7 levels and glioma malignancy, with higher expression in grade IV gliomas compared with grade II gliomas, indicating its potential as a prognostic marker [146]. The gene discussed is SIRT7; the disease is central nervous system cancer.